Pendulum
The Next Generation of Probiotics
San Francisco, United States · Founded 2013 · $22.0M raised
- Headquarters
- San Francisco, California
- Employees
- 51–200
- Founded
- 2013
- Business Model
- B2C
- Website
- pendulumlife.com
- Total Funding
- $22.0M
- Last Round
- $22.0M Venture RoundFeb 2025
- Rounds
- 1
About
Pendulum Therapeutics is the leading innovator in microbiome science, delivering research-based probiotic formulations to support metabolic health. The company leverages cutting-edge research and strong intellectual property to bring effective, science-backed solutions to consumers worldwide. Pendulum Akkermansia was the first novel probiotic species brought to market in more than 50 years and is the first and only probiotic clinically proven to lower A1C and blood glucose in people with type 2 diabetes by stimulating natural GLP-1 production. The product line includes Metabolic Daily, Akkermansia, Glucose Control, and Polyphenol Booster, sold direct-to-consumer and through healthcare provider channels.
Summary
Pendulum is a Biotech company based in San Francisco, United States, founded in 2013. It has raised $22.0M in total across 1 round, most recently a $22.0M Venture Round round in Feb 2025.
Tech & App Stack
7 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Feb 2025
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...